Watchlist Price Alert

Meridian Bioscience Inc. (VIVO)

NASDAQ: VIVO · Real-Time Price · USD

33.97

0.00 (0.00%)

At close: Jan 30, 2023, 10:00 PM

Meridian Bioscience Balance Sheet Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
Cash & Equivalents	81.45M	49.77M	53.51M	62.4M	59.76M	57.07M	47.23M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	-8.2M
Other Long-Term Assets	2.08M	365K	585K	510K	4.45M	3.6M	2.75M
Receivables	47.23M	53.57M	38.51M	35.61M	32.34M	29.11M	27.1M
Inventory	67.81M	76.84M	61.26M	39.62M	41.99M	41.49M	45.06M
Other Current Assets	14.1M	12.63M	8.9M	7.14M	4.96M	6.2M	7.41M
Total Current Assets	210.6M	192.81M	162.19M	144.76M	139.05M	133.88M	126.79M
Property-Plant & Equipment	50.71M	49M	37.46M	30.57M	30M	30.51M	30.45M
Goodwill & Intangibles	190.43M	198.82M	197.38M	149.48M	77.75M	81.63M	91.84M
Total Long-Term Assets	252.5M	256.92M	243.07M	180.72M	112.32M	115.9M	125.03M
Total Assets	463.1M	449.72M	405.26M	325.48M	251.38M	249.78M	251.82M
Account Payables	17.76M	11.7M	11.97M	7.24M	6.26M	7.72M	7.63M
Deferred Revenue	667K	638K	600K	n/a	335K	1.25M	1.48M
Short-Term Debt	1.83M	1.99M	1.79M	n/a	5.25M	4.5M	3.75M
Other Current Liabilities	37.7M	32.83M	38.17M	13.68M	12.33M	9.42M	9.71M
Total Current Liabilities	57.95M	47.16M	52.52M	20.91M	24.17M	22.89M	22.57M
Long-Term Debt	29.13M	63.93M	68.82M	75.82M	44.93M	50.15M	54.61M
Other Long-Term Liabilities	7.96M	10.33M	21.96M	37.77M	6.86M	7.16M	5.42M
Total Long-Term Liabilities	37.09M	74.26M	105.11M	113.6M	51.79M	57.3M	62.78M
Total Liabilities	95.04M	121.42M	157.63M	134.51M	75.96M	80.19M	85.35M
Total Debt	30.96M	65.92M	70.61M	75.82M	50.18M	54.65M	58.36M
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	223.16M	180.7M	109.29M	63.11M	49.6M	46.92M	49.63M
Comprehensive Income	-10.5M	198K	-1.86M	-4.97M	-3.38M	-2.95M	-5.52M
Shareholders Equity	368.06M	328.3M	247.63M	190.97M	175.42M	169.59M	166.47M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	-8.2M